November 13, 2024- November marks American Diabetes Month®, a time to raise awareness of diabetes and to support the 1.2 million Americans diagnosed with diabetes each year, and more than 38 million Americans affected by the disease. In this video, Dr. Lucienne Ide, Founder and CEO of Rimidi, highlights three advancements in diabetes care.
Rimidi’s remote patient monitoring solution for diabetes, available through Henry Schein Medical, connects patient-generated data from connected devices like blood glucose monitors, continuous glucose monitors, and insulin pens with clinical data in electronic health record (EHR) systems. This helps give clinicians a more complete view of a patient’s health and drives patient-specific clinical insights and actions within the framework of the latest evidence and guidelines. The platform lives within the EHR—integrating seamlessly into the provider workflow.
For more information about Rimidi, please click here.